Viewing Study NCT05405595


Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2026-01-29 @ 7:06 AM
Study NCT ID: NCT05405595
Status: RECRUITING
Last Update Posted: 2025-06-04
First Post: 2022-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Sponsor: Adagene Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module